We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How product specific rules are used to identify the country of origin when importing or exporting between the UK and EU.
Eligibility criteria for products to be included on the Energy Technology List.
When tests to detect COVID-19 are commonly used (use cases) and what to consider when deciding which type of test to employ.
Listing of countries with a known occurrence of high consequence infectious disease (HCID).
When you need to use a movement licence and designated slaughterhouses for bluetongue restricted premises.
Use these general provisions to help you determine the origin of your products.
This guidance provides an overview of the different tariffs for products exported to the UK under the DCTS, including how to identify commodity codes.
An overview of the future requirements for rapid COVID-19 diagnostic assays for antigen lateral flow devices.
How to use an ethnographic study to evaluate your digital health product.
The Valuation Office Agency (VOA) asks for rental and lease information to assess the rateable value of non-domestic properties.
Check if you can apply for Authorised Use relief to reduce your payments when you import goods for a specific use. This can include repairs, maintenance or processing.
Apply for an authorisation to manufacture extemporaneous preparations, autogenous vaccines, stem cell products or blood products for non-food animals.
This article focuses on one specific evaluation, of an irrigation project in Malawi
How to use a cost effectiveness analysis to evaluate your digital health product.
Guidance on the Specific Batch Control (SBC) scheme for release of product on to the UK market.
Guidance for healthcare professionals on managing specific medicines and medical devices and using them safely.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Using an ecological momentary assessment to evaluate your digital health product.
Guidance on additional risk assessments you will need to do for an environmental permit and information about the H1 software tool.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).